Product NDC: | 40032-620 |
Proprietary Name: | Levonorgestrel |
Non Proprietary Name: | Levonorgestrel |
Active Ingredient(s): | 1.5 mg/1 & nbsp; Levonorgestrel |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 40032-620 |
Labeler Name: | Novel Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202508 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130222 |
Package NDC: | 40032-620-30 |
Package Description: | 1 TABLET in 1 CARTON (40032-620-30) |
NDC Code | 40032-620-30 |
Proprietary Name | Levonorgestrel |
Package Description | 1 TABLET in 1 CARTON (40032-620-30) |
Product NDC | 40032-620 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levonorgestrel |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130222 |
Marketing Category Name | ANDA |
Labeler Name | Novel Laboratories, Inc. |
Substance Name | LEVONORGESTREL |
Strength Number | 1.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |